Up next

Autoplay

Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

4 Views • 07/18/23
Share
Embed
administrator
administrator
Subscribers
0

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay